'Before Medically Advised' Discharge Linked to Risk for Overdose
MONDAY, Sept. 23, 2024 -- 'Before medically advised' (BMA) discharge from the hospital is associated with an increased risk for subsequent drug overdose, according to a study published online Sept. 23 in CMAJ, the journal of the Canadian Medical Association.
Mayesha Khan, from the University of British Columbia in Vancouver, Canada, and colleagues conducted a retrospective cohort study using administrative health data from a 20 percent random sample of residents of British Columbia, Canada, to examine whether BMA discharge increases the risk for subsequent drug overdose. A survival analysis was used to compare the rate of fatal and nonfatal illicit drug overdose in the first 30 days after BMA discharge versus after physician-advised discharge.
Overall, 3.4 percent of the 189,808 hospital stays ended in BMA discharge. The researchers found that 92 percent of the 820 overdoses occurring in the first 30 days after any hospital discharge involved patients with a history of substance use disorder. The unadjusted overdose rates were 10-fold higher after BMA versus physician-advised discharge; even after adjustment for potential confounders, BMA discharge was associated with subsequent overdose (crude incidence, 2.8 versus 0.3 percent; adjusted hazard ratio, 1.58). Increases in subsequent emergency department visits and unplanned hospital readmissions were seen in association with BMA (adjusted hazard ratio, 1.92 and 2.07, respectively); no significant association was seen with fatal overdoses and all-cause mortality.
"Hospitals and health systems should develop evidence-based protocols to prevent BMA discharge and should explore novel means of postdeparture outreach to reduce the risk of drug overdose after hospital discharge," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
One in 10 Undergoing Early Cancer Surgery Have New Persistent Opioid Use
MONDAY, Sept. 8, 2025 -- More than one in 10 veterans undergoing surgery for early-stage cancer develop new persistent opioid use, according to a study published online Sept. 8 in...
2000 to 2023 Saw Rise in Pediatric Exposure to Medications, Supplements
MONDAY, Sept. 8, 2025 -- From 2000 to 2023, the rate of exposure to medications, dietary supplements, and psychoactive substances increased among children aged 6 to 12 years...
Buprenorphine Available at 39.4 Percent of U.S. Pharmacies in 2023
WEDNESDAY, Sept. 3, 2025 -- From 2017 to 2023, there was an increase in buprenorphine availability overall, reaching 39.4 percent in 2023, according to a study published online...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.